DelMar Pharmaceuticals Inc (NASDAQ:DMPI)

1.03
Delayed Data
As of Apr 20
 +0.03 / +3.00%
Today’s Change
0.78
Today|||52-Week Range
2.98
-5.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization0.000.0010.3K16.7K
 
 
 
 
Operating ExpensesGross Income0.000.00-10.3K-16.7K
 
 
 
General Expenses6.3M4.7M6.2M8.3M
 
 
 
 
 
Research And Development2.3M2.6M3.4M5.0M
 
 
 
 
 
Total Operating Expenses6.3M4.7M6.2M8.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.3M-4.7M-6.2M-8.3M
 
 
 
 
 
Extraordinary Credit--651.1K0.00246.0K
 
 
 
Extraordinary Charge-1.4M-249.1K-2.6M0.00
 
 
 
 
Interest Expense On Debt8.0K2.1K0.000.00
 
 
 
Other Expenses-601.0K-23.4K-13.8K-7.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.3M-4.3M-8.9M-8.1M
 
 
 
 
 
Preferred Dividend0.00--0.00-790.5K
 
 
Net Income-8.3M-4.3M-8.9M-8.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS7.4M9.5M10.9M12.0M
 
 
 
 
 
Shares To Calculate EPS Diluted7.4M9.5M10.9M12.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.12-$0.44-$0.81-$0.74
 
 
 
 
 
EPS Diluted-$1.12-$0.44-$0.81-$0.74